BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25734836)

  • 1. Conditional control of alternative splicing through light-triggered splice-switching oligonucleotides.
    Hemphill J; Liu Q; Uprety R; Samanta S; Tsang M; Juliano RL; Deiters A
    J Am Chem Soc; 2015 Mar; 137(10):3656-62. PubMed ID: 25734836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Tak1 alternative splicing by splice-switching oligonucleotides.
    Zhou D; Shao Q; Fan X; Wu P; Lin W; Wei H; He F; Jiang Y
    Biochem Biophys Res Commun; 2018 Mar; 497(4):1018-1024. PubMed ID: 29475001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines.
    Li Z; Li Q; Han L; Tian N; Liang Q; Li Y; Zhao X; Du C; Tian Y
    Oncol Rep; 2016 Feb; 35(2):1013-9. PubMed ID: 26718027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of therapeutic splice-switching oligonucleotides.
    Disterer P; Kryczka A; Liu Y; Badi YE; Wong JJ; Owen JS; Khoo B
    Hum Gene Ther; 2014 Jul; 25(7):587-98. PubMed ID: 24826963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching on transgene expression by correcting aberrant splicing using multi-targeting steric-blocking oligonucleotides.
    Resina S; Kole R; Travo A; Lebleu B; Thierry AR
    J Gene Med; 2007 Jun; 9(6):498-510. PubMed ID: 17471591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optochemical control of deoxyoligonucleotide function via a nucleobase-caging approach.
    Liu Q; Deiters A
    Acc Chem Res; 2014 Jan; 47(1):45-55. PubMed ID: 23981235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor activity of splice-switching oligonucleotides.
    Bauman JA; Li SD; Yang A; Huang L; Kole R
    Nucleic Acids Res; 2010 Dec; 38(22):8348-56. PubMed ID: 20719743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of AI/ML derived splice-switching oligonucleotides.
    Fronk AD; Manzanares MA; Zheng P; Geier A; Anderson K; Stanton S; Zumrut H; Gera S; Munch R; Frederick V; Dhingra P; Arun G; Akerman M
    Mol Syst Biol; 2024 Jun; 20(6):676-701. PubMed ID: 38664594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of telomerase activity by splice-switching oligonucleotides targeting the mRNA of the telomerase catalytic subunit affects proliferation of human CD4
    Zhdanov DD; Plyasova AA; Gladilina YA; Pokrovsky VS; Grishin DV; Grachev VA; Orlova VS; Pokrovskaya MV; Alexandrova SS; Lobaeva TA; Sokolov NN
    Biochem Biophys Res Commun; 2019 Feb; 509(3):790-796. PubMed ID: 30612734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of splice-switching oligonucleotides.
    Bauman J; Jearawiriyapaisarn N; Kole R
    Oligonucleotides; 2009 Mar; 19(1):1-13. PubMed ID: 19125639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splice-switching antisense oligonucleotides as therapeutic drugs.
    Havens MA; Hastings ML
    Nucleic Acids Res; 2016 Aug; 44(14):6549-63. PubMed ID: 27288447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and In Vitro Evaluation of Splice-Switching Oligonucleotides Bearing Locked Nucleic Acids, Amido-Bridged Nucleic Acids, and Guanidine-Bridged Nucleic Acids.
    Shimo T; Nakatsuji Y; Tachibana K; Obika S
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of minigene systems to dissect alternative splicing elements.
    Cooper TA
    Methods; 2005 Dec; 37(4):331-40. PubMed ID: 16314262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of MKNK2 alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment.
    Mogilevsky M; Shimshon O; Kumar S; Mogilevsky A; Keshet E; Yavin E; Heyd F; Karni R
    Nucleic Acids Res; 2018 Nov; 46(21):11396-11404. PubMed ID: 30329087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 2'-O-(N-methylcarbamoylethyl) 5-methyl-2-thiouridine and its application to splice-switching oligonucleotides.
    Masaki Y; Yamamoto K; Inde T; Yoshida K; Maruyama A; Nagata T; Tanihata J; Takeda S; Sekine M; Seio K
    Bioorg Med Chem Lett; 2019 Jan; 29(2):160-163. PubMed ID: 30551900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of RNA splicing as a potential treatment for cancer.
    Bauman JA; Kole R
    Bioeng Bugs; 2011; 2(3):125-8. PubMed ID: 21637003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA modulation, repair and remodeling by splice switching oligonucleotides.
    Kole R; Williams T; Cohen L
    Acta Biochim Pol; 2004; 51(2):373-8. PubMed ID: 15218534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient and persistent splice switching by systemically delivered LNA oligonucleotides in mice.
    Roberts J; Palma E; Sazani P; Ørum H; Cho M; Kole R
    Mol Ther; 2006 Oct; 14(4):471-5. PubMed ID: 16854630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart.
    Ashiya M; Grabowski PJ
    RNA; 1997 Sep; 3(9):996-1015. PubMed ID: 9292499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conserved RNA cis-elements regulate alternative splicing of Lepidopteran doublesex.
    Wang XY; Zheng ZZ; Song HS; Xu YZ
    Insect Biochem Mol Biol; 2014 Jan; 44():1-11. PubMed ID: 24239545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.